Literature DB >> 25458846

SGK3 mediates INPP4B-dependent PI3K signaling in breast cancer.

Jessica A Gasser1, Hiroyuki Inuzuka1, Alan W Lau1, Wenyi Wei1, Rameen Beroukhim2, Alex Toker3.   

Abstract

Oncogenic mutations in PIK3CA, the gene encoding the catalytic subunit of phosphoinositide 3-kinase (PI3K), occur with high frequency in breast cancer. The protein kinase Akt is considered to be the primary effector of PIK3CA, although mechanisms by which PI3K mediates Akt-independent tumorigenic signals remain obscure. We show that serum and glucocorticoid-regulated kinase 3 (SGK3) is amplified in breast cancer and activated downstream of PIK3CA in a manner dependent on the phosphoinositide phosphatase INPP4B. Expression of INPP4B leads to enhanced SGK3 activation and suppression of Akt phosphorylation. Activation of SGK3 downstream of PIK3CA and INPP4B is required for 3D proliferation, invasive migration, and tumorigenesis in vivo. We further show that SGK3 targets the metastasis suppressor NDRG1 for degradation by Fbw7. We propose a model in which breast cancers harboring oncogenic PIK3CA activate SGK3 signaling while suppressing Akt, indicative of oncogenic functions for both INPP4B and SGK3 in these tumors.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25458846      PMCID: PMC4255362          DOI: 10.1016/j.molcel.2014.09.023

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  61 in total

Review 1.  Stimulus-dependent regulation of serum and glucocorticoid inducible protein kinase (SGK) transcription, subcellular localization and enzymatic activity.

Authors:  Gary L Firestone; Jennifer R Giampaolo; Bridget A O'Keeffe
Journal:  Cell Physiol Biochem       Date:  2003

Review 2.  Targeting the PI3K-Akt pathway in human cancer: rationale and promise.

Authors:  Ji Luo; Brendan D Manning; Lewis C Cantley
Journal:  Cancer Cell       Date:  2003-10       Impact factor: 31.743

3.  Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures.

Authors:  Jayanta Debnath; Senthil K Muthuswamy; Joan S Brugge
Journal:  Methods       Date:  2003-07       Impact factor: 3.608

4.  Characterization of the structure and regulation of two novel isoforms of serum- and glucocorticoid-induced protein kinase.

Authors:  T Kobayashi; M Deak; N Morrice; P Cohen
Journal:  Biochem J       Date:  1999-11-15       Impact factor: 3.857

5.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.

Authors:  T Sørlie; C M Perou; R Tibshirani; T Aas; S Geisler; H Johnsen; T Hastie; M B Eisen; M van de Rijn; S S Jeffrey; T Thorsen; H Quist; J C Matese; P O Brown; D Botstein; P E Lønning; A L Børresen-Dale
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

6.  Phosphatidylinositol (3,4,5)P3 is essential but not sufficient for protein kinase B (PKB) activation; phosphatidylinositol (3,4)P2 is required for PKB phosphorylation at Ser-473: studies using cells from SH2-containing inositol-5-phosphatase knockout mice.

Authors:  Michael P Scheid; Michael Huber; Jacqueline E Damen; Michael Hughes; Veronica Kang; Paul Neilsen; Glenn D Prestwich; Gerald Krystal; Vincent Duronio
Journal:  J Biol Chem       Date:  2002-01-07       Impact factor: 5.157

7.  Molecular mechanism of membrane binding of the GRP1 PH domain.

Authors:  Chun-Liang Lai; Anand Srivastava; Carissa Pilling; Anna R Chase; Joseph J Falke; Gregory A Voth
Journal:  J Mol Biol       Date:  2013-06-06       Impact factor: 5.469

8.  PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.

Authors:  Yong Choi; Jie Zhang; Cristina Murga; Hong Yu; Erich Koller; Brett P Monia; J Silvio Gutkind; Weiqun Li
Journal:  Oncogene       Date:  2002-08-08       Impact factor: 9.867

9.  Inactivation of hCDC4 can cause chromosomal instability.

Authors:  Harith Rajagopalan; Prasad V Jallepalli; Carlo Rago; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Christoph Lengauer
Journal:  Nature       Date:  2004-03-04       Impact factor: 49.962

10.  Regulation of cytokine-independent survival kinase (CISK) by the Phox homology domain and phosphoinositides.

Authors:  J Xu; D Liu; G Gill; Z Songyang
Journal:  J Cell Biol       Date:  2001-08-20       Impact factor: 10.539

View more
  68 in total

1.  Oncogenic Ras differentially regulates metabolism and anoikis in extracellular matrix-detached cells.

Authors:  J A Mason; C A Davison-Versagli; A K Leliaert; D J Pape; C McCallister; J Zuo; S M Durbin; C L Buchheit; S Zhang; Z T Schafer
Journal:  Cell Death Differ       Date:  2016-02-26       Impact factor: 15.828

2.  INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC.

Authors:  Darien E Reed; Kevan M Shokat
Journal:  Mol Cancer Res       Date:  2017-02-14       Impact factor: 5.852

Review 3.  The PI3K Pathway in Human Disease.

Authors:  David A Fruman; Honyin Chiu; Benjamin D Hopkins; Shubha Bagrodia; Lewis C Cantley; Robert T Abraham
Journal:  Cell       Date:  2017-08-10       Impact factor: 41.582

4.  Phosphoinositide 3-kinase inhibitors induce DNA damage through nucleoside depletion.

Authors:  Ashish Juvekar; Hai Hu; Sina Yadegarynia; Costas A Lyssiotis; Soumya Ullas; Evan C Lien; Gary Bellinger; Jaekyoung Son; Rosanna C Hok; Pankaj Seth; Michele B Daly; Baek Kim; Ralph Scully; John M Asara; Lewis C Cantley; Gerburg M Wulf
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-08       Impact factor: 11.205

Review 5.  PI3K signaling in cancer: beyond AKT.

Authors:  Evan C Lien; Christian C Dibble; Alex Toker
Journal:  Curr Opin Cell Biol       Date:  2017-03-24       Impact factor: 8.382

6.  Skp2-dependent reactivation of AKT drives resistance to PI3K inhibitors.

Authors:  Emilie Clement; Hiroyuki Inuzuka; Naoe T Nihira; Wenyi Wei; Alex Toker
Journal:  Sci Signal       Date:  2018-03-13       Impact factor: 8.192

Review 7.  PI3K Inhibitors in Cancer: Clinical Implications and Adverse Effects.

Authors:  Rosalin Mishra; Hima Patel; Samar Alanazi; Mary Kate Kilroy; Joan T Garrett
Journal:  Int J Mol Sci       Date:  2021-03-27       Impact factor: 5.923

8.  INPP4B Is a Tumor Suppressor in the Context of PTEN Deficiency.

Authors:  Thanh-Trang T Vo; David A Fruman
Journal:  Cancer Discov       Date:  2015-07       Impact factor: 39.397

9.  INPP4B-mediated DNA repair pathway confers resistance to chemotherapy in acute myeloid leukemia.

Authors:  Ping Wang; Dan Ma; Jishi Wang; Qin Fang; Rui Gao; Weibing Wu; Lu Cao; Xiuying Hu; Jiangyuan Zhao; Yan Li
Journal:  Tumour Biol       Date:  2016-06-24

10.  Multiplexed immunofluorescence delineates proteomic cancer cell states associated with metabolism.

Authors:  Anup Sood; Alexandra M Miller; Edi Brogi; Yunxia Sui; Joshua Armenia; Elizabeth McDonough; Alberto Santamaria-Pang; Sean Carlin; Aleksandra Stamper; Carl Campos; Zhengyu Pang; Qing Li; Elisa Port; Thomas G Graeber; Nikolaus Schultz; Fiona Ginty; Steven M Larson; Ingo K Mellinghoff
Journal:  JCI Insight       Date:  2016-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.